2型糖尿病患者尿微量白蛋白检测的临床意义

目的探讨尿微量白蛋白检测在2型糖尿病（T2DM）患者中的临床价值。方法随机选取临床确诊的60例T2DM患者，另将60例健康体检者作为对照组。2组分别测定空腹血糖和尿微量白蛋白。结果对照组空腹血糖和尿微量白蛋白分别为（4．82±1．59）mmol／L和（18．60±4．48）mg／d，T2DM组空腹血糖和尿微量白蛋白数值较对照组明显升高，分别为（15．65±4．97）mmol／L和（64．77±11．59）mg／d，2组比较差异有统计学意义（P〈0．01）。结论T2DM患者微量白蛋白尿发生率较高，尿微量白蛋白检测可以作为T2DM患者的常规检查项目。

The Clinical Significance of Testing MAU on the Patients of T2 DM

Objective To discuss the clinical significance of the testing MAU on the patients of T2DM. Method To select 60 confirmed T2DM patients at random, and set 60 healthy persons in a group for comparative study. Both groups were tested for fasting blood sugar and MAU. Results The fasting blood sugar figure and the MAU figure of the comparison group were （4.82±1.59） mmol/L and （18.60±4.48） mg/d, while the same figures of the T2DM group were markedly higher than the comparison group, registering at （15.65 ±4.97） mmol/L and （64.77 ±11.59） mg/d. The differences of the two groups were statistically significant （P〈0.01）. Conclusion MAU occurs rather frequently among T2DM patients, and a test of MAU can be made a content of regular examination for T2 DM patients.